Detalles de la búsqueda
1.
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Transfusion
; 60(8): 1867-1872, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32654201
2.
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
Cancer
; 124(1): 136-144, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28902390
3.
Randomized phase 3 study in low-grade lymphoma comparing maintenance anti-CD20 antibody with observation after induction therapy: A trial of the ECOG-ACRIN Cancer Research Group (E1496).
Cancer
; 122(19): 2996-3004, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27351685
4.
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402.
Br J Haematol
; 173(6): 867-75, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26970533
5.
Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405).
Blood
; 123(11): 1665-73, 2014 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24458437
6.
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).
Br J Haematol
; 170(1): 56-65, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25823885
7.
A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B-cell non-Hodgkin lymphoma: ECOG3402.
Br J Haematol
; 170(5): 679-86, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25974212
8.
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
Br J Haematol
; 171(4): 530-8, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26343802
9.
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.
N Engl J Med
; 366(5): 399-408, 2012 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-22149921
10.
Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience.
Blood
; 122(6): 981-7, 2013 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-23777769
11.
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
Blood
; 121(18): 3547-53, 2013 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23386127
12.
Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial.
Blood
; 120(16): 3280-7, 2012 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-22948049
13.
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496.
Br J Haematol
; 161(1): 76-86, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23356491
14.
Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium.
Blood
; 117(26): 7070-8, 2011 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21536860
15.
Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma.
Br J Haematol
; 159(3): 329-39, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22966754
16.
Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study.
Blood
; 115(4): 775-7; quiz 918, 2010 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-19767508
17.
Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma.
Biol Blood Marrow Transplant
; 16(8): 1145-54, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20197102
18.
Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI).
Br J Haematol
; 151(2): 143-51, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20735398
19.
Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP).
Br J Haematol
; 148(2): 235-44, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19821819
20.
Patient priority in the era of patent expiries.
Lancet Oncol
; 15(11): e474, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25281466